Cargando…

Potent human uric acid transporter 1 inhibitors: in vitro and in vivo metabolism and pharmacokinetic studies

Human uric acid transporter 1 (hURAT1; SLC22A12) is a very important urate anion exchanger. Elevated urate levels are known to play a pivotal role in cardiovascular diseases, chronic renal disease, diabetes, and hypertension. Therefore, the development of potent uric acid transport inhibitors may le...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wempe, Michael F, Lightner, Janet W, Miller, Bettina, Iwen, Timothy J, Rice, Peter J, Wakui, Shin, Anzai, Naohiko, Jutabha, Promsuk, Endou, Hitoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496402/ https://www.ncbi.nlm.nih.gov/pubmed/23152669 http://dx.doi.org/10.2147/DDDT.S35805

Ejemplares similares

Molecular Mechanism of Ochratoxin A Transport in the Kidney
por: Anzai, Naohiko, et al.
Publicado: (2010)

Uric acid lowering in relation to HbA1c reductions with the SGLT2 inhibitor tofogliflozin
por: Ouchi, Motoshi, et al.
Publicado: (2018)

Distinct action of the α-glucosidase inhibitor miglitol on SGLT3, enteroendocrine cells, and GLP1 secretion
por: Lee, Eun Young, et al.
Publicado: (2015)

Contribution of Rare Variants of the SLC22A12 Gene to the Missing Heritability of Serum Urate Levels
por: Misawa, Kazuharu, et al.
Publicado: (2020)

Clinical and Functional Characterization of URAT1 Variants
por: Tasic, Velibor, et al.
Publicado: (2011)

Nuclear Morphometric Analysis of Leydig Cells of Male Pubertal Rats Exposed In Utero to Di(n-butyl) Phthalate
por: Wakui, Shin, et al.
Publicado: (2013)

Retraction: Nuclear Morphometric Analysis of Leydig Cells of Male Pubertal Rats Exposed In Utero to Di(n-butyl) Phthalate
por: Wakui, Shin, et al.
Publicado: (2023)

JPH203, a selective L-type amino acid transporter 1 inhibitor, induces mitochondria-dependent apoptosis in Saos2 human osteosarcoma cells
por: Choi, Dae Woo, et al.
Publicado: (2017)

Inhibition of the amino‐acid transporter LAT1 demonstrates anti‐neoplastic activity in medulloblastoma
por: Cormerais, Yann, et al.
Publicado: (2019)

The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5)
por: Cormerais, Yann, et al.
Publicado: (2018)

Novel therapeutic approaches targeting L-type amino acid transporters for cancer treatment
por: Hayashi, Keitaro, et al.
Publicado: (2017)

Hypouricemia and Urate Transporters
por: Otani, Naoyuki, et al.
Publicado: (2022)

Discovery of a Flexible Triazolylbutanoic Acid as a Highly Potent Uric Acid Transporter 1 (URAT1) Inhibitor
por: Tian, He, et al.
Publicado: (2016)

Proteomics and phosphoproteomics reveal key regulators associated with cytostatic effect of amino acid transporter LAT1 inhibitor
por: Okanishi, Hiroki, et al.
Publicado: (2020)

Recent advances on uric acid transporters
por: Xu, Liuqing, et al.
Publicado: (2017)

Uric acid transporters BCRP and MRP4 involved in chickens uric acid excretion
por: Ding, Xuedong, et al.
Publicado: (2019)

Phosphoproteomics revealed cellular signals immediately responding to disruption of cancer amino acid homeostasis induced by inhibition of l-type amino acid transporter 1
por: Okanishi, Hiroki, et al.
Publicado: (2022)

Function of Uric Acid Transporters and Their Inhibitors in Hyperuricaemia
por: Sun, Hao-lu, et al.
Publicado: (2021)

Intra-Aortic Swinging Mass
por: Yoshikawa, Haruna, et al.
Publicado: (2019)

Potent in vivo anti-malarial activity and representative snapshot pharmacokinetic evaluation of artemisinin-quinoline hybrids
por: Lombard, Marli C, et al.
Publicado: (2013)

Pharmacologic inhibition of LAT1 predominantly suppresses transport of large neutral amino acids and downregulates global translation in cancer cells
por: Nishikubo, Kou, et al.
Publicado: (2022)

Combination effects of amino acid transporter LAT1 inhibitor nanvuranlat and cytotoxic anticancer drug gemcitabine on pancreatic and biliary tract cancer cells
por: Nishikubo, Kou, et al.
Publicado: (2023)

Inhibitors of Human 5-Lipoxygenase Potently Interfere With Prostaglandin Transport
por: Kahnt, Astrid S., et al.
Publicado: (2022)

High expression of L-type amino acid transporter 1 as a prognostic marker in bile duct adenocarcinomas
por: Yanagisawa, Nobuyuki, et al.
Publicado: (2014)

Systematic Structure-Activity Relationship (SAR) Exploration of Diarylmethane Backbone and Discovery of A Highly Potent Novel Uric Acid Transporter 1 (URAT1) Inhibitor
por: Cai, Wenqing, et al.
Publicado: (2018)

Resveratrol affects the expression of uric acid transporter by improving inflammation
por: Zhang, Xuemei, et al.
Publicado: (2021)

High-Affinity PEGylated Polyacridine Peptide Polyplexes Mediate Potent In Vivo Gene Expression
por: Kizzire, Koby, et al.
Publicado: (2012)

Inhibition of cancer-type amino acid transporter LAT1 suppresses B16-F10 melanoma metastasis in mouse models
por: Shi, Zitong, et al.
Publicado: (2023)

Chicken serum uric acid level is regulated by glucose transporter 9
por: Ding, Xuedong, et al.
Publicado: (2021)

SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria
por: Chino, Yukihiro, et al.
Publicado: (2014)

Differences of Uric Acid Transporters Carrying Extracellular Vesicles in the Urine from Uric Acid and Calcium Stone Formers and Non-Stone Formers
por: Lin, Zhijian, et al.
Publicado: (2022)

Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Verinurad, a Selective Uric Acid Reabsorption Inhibitor
por: Smith, William B., et al.
Publicado: (2018)

Glucose Transporter 9 (GLUT9) Plays an Important Role in the Placental Uric Acid Transport System
por: Lüscher, Benjamin P., et al.
Publicado: (2022)

Mutation in Transmembrane Domain 8 of Human Urate Transporter 1 Disrupts Uric Acid Recognition and Transport
por: Lan, Qunsheng, et al.
Publicado: (2022)

Contribution of the L-Type Amino Acid Transporter Family in the Diagnosis and Treatment of Prostate Cancer
por: Zhao, Xue, et al.
Publicado: (2023)

Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 activation
por: Quan, Lili, et al.
Publicado: (2020)

Uric acid: a potent molecular contributor to pluripotent stem cell cardiac differentiation via mesoderm specification
por: Ke, Bingbing, et al.
Publicado: (2018)

High Uric Acid Induces Insulin Resistance in Cardiomyocytes In Vitro and In Vivo
por: Zhi, Li, et al.
Publicado: (2016)

Exercise serum regulates uric acid transporters in normal rat kidney cells
por: Jiang, Zhongye, et al.
Publicado: (2022)

Pharmacokinetics, pharmacodynamics, and safety of lesinurad, a selective uric acid reabsorption inhibitor, in healthy adult males
por: Shen, Zancong, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mpajfmhkcc4mgrrssn281c6pnr